Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study
Gespeichert in:
| Autor*in: |
Cohen, Alexander T. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:206 ; year:2021 ; pages:1-4 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.thromres.2021.06.021 |
|---|
| Katalog-ID: |
ELV05544055X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV05544055X | ||
| 003 | DE-627 | ||
| 005 | 20230624221626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2021.06.021 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica |
| 035 | |a (DE-627)ELV05544055X | ||
| 035 | |a (ELSEVIER)S0049-3848(21)00381-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Cohen, Alexander T. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| 264 | 1 | |c 2021 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Maraveyas, Anthony |4 oth | |
| 700 | 1 | |a Beyer-Westendorf, Jan |4 oth | |
| 700 | 1 | |a Lee, Agnes Y.Y. |4 oth | |
| 700 | 1 | |a Folkerts, Kerstin |4 oth | |
| 700 | 1 | |a Abdelgawwad, Khaled |4 oth | |
| 700 | 1 | |a De Sanctis, Yoriko |4 oth | |
| 700 | 1 | |a Fatoba, Samuel |4 oth | |
| 700 | 1 | |a Bamber, Luke |4 oth | |
| 700 | 1 | |a Bach, Miriam |4 oth | |
| 700 | 1 | |a Mantovani, Lorenzo G. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
| 773 | 1 | 8 | |g volume:206 |g year:2021 |g pages:1-4 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.thromres.2021.06.021 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 206 |j 2021 |h 1-4 |g 4 | ||
| author_variant |
a t c at atc |
|---|---|
| matchkey_str |
cohenalexandertmaraveyasanthonybeyerwest:2021----:ainrpreotoeascaewtcagntrvrxbnoteramnocneascaev |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.40 |
| publishDate |
2021 |
| allfields |
10.1016/j.thromres.2021.06.021 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica (DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Cohen, Alexander T. verfasserin aut Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study 2021 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maraveyas, Anthony oth Beyer-Westendorf, Jan oth Lee, Agnes Y.Y. oth Folkerts, Kerstin oth Abdelgawwad, Khaled oth De Sanctis, Yoriko oth Fatoba, Samuel oth Bamber, Luke oth Bach, Miriam oth Mantovani, Lorenzo G. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:206 year:2021 pages:1-4 extent:4 https://doi.org/10.1016/j.thromres.2021.06.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 206 2021 1-4 4 |
| spelling |
10.1016/j.thromres.2021.06.021 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica (DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Cohen, Alexander T. verfasserin aut Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study 2021 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maraveyas, Anthony oth Beyer-Westendorf, Jan oth Lee, Agnes Y.Y. oth Folkerts, Kerstin oth Abdelgawwad, Khaled oth De Sanctis, Yoriko oth Fatoba, Samuel oth Bamber, Luke oth Bach, Miriam oth Mantovani, Lorenzo G. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:206 year:2021 pages:1-4 extent:4 https://doi.org/10.1016/j.thromres.2021.06.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 206 2021 1-4 4 |
| allfields_unstemmed |
10.1016/j.thromres.2021.06.021 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica (DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Cohen, Alexander T. verfasserin aut Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study 2021 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maraveyas, Anthony oth Beyer-Westendorf, Jan oth Lee, Agnes Y.Y. oth Folkerts, Kerstin oth Abdelgawwad, Khaled oth De Sanctis, Yoriko oth Fatoba, Samuel oth Bamber, Luke oth Bach, Miriam oth Mantovani, Lorenzo G. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:206 year:2021 pages:1-4 extent:4 https://doi.org/10.1016/j.thromres.2021.06.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 206 2021 1-4 4 |
| allfieldsGer |
10.1016/j.thromres.2021.06.021 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica (DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Cohen, Alexander T. verfasserin aut Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study 2021 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maraveyas, Anthony oth Beyer-Westendorf, Jan oth Lee, Agnes Y.Y. oth Folkerts, Kerstin oth Abdelgawwad, Khaled oth De Sanctis, Yoriko oth Fatoba, Samuel oth Bamber, Luke oth Bach, Miriam oth Mantovani, Lorenzo G. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:206 year:2021 pages:1-4 extent:4 https://doi.org/10.1016/j.thromres.2021.06.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 206 2021 1-4 4 |
| allfieldsSound |
10.1016/j.thromres.2021.06.021 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica (DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Cohen, Alexander T. verfasserin aut Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study 2021 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Maraveyas, Anthony oth Beyer-Westendorf, Jan oth Lee, Agnes Y.Y. oth Folkerts, Kerstin oth Abdelgawwad, Khaled oth De Sanctis, Yoriko oth Fatoba, Samuel oth Bamber, Luke oth Bach, Miriam oth Mantovani, Lorenzo G. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:206 year:2021 pages:1-4 extent:4 https://doi.org/10.1016/j.thromres.2021.06.021 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 206 2021 1-4 4 |
| language |
English |
| source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:206 year:2021 pages:1-4 extent:4 |
| sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:206 year:2021 pages:1-4 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| authorswithroles_txt_mv |
Cohen, Alexander T. @@aut@@ Maraveyas, Anthony @@oth@@ Beyer-Westendorf, Jan @@oth@@ Lee, Agnes Y.Y. @@oth@@ Folkerts, Kerstin @@oth@@ Abdelgawwad, Khaled @@oth@@ De Sanctis, Yoriko @@oth@@ Fatoba, Samuel @@oth@@ Bamber, Luke @@oth@@ Bach, Miriam @@oth@@ Mantovani, Lorenzo G. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011105356 |
| dewey-sort |
3610 |
| id |
ELV05544055X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05544055X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624221626.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2021.06.021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05544055X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(21)00381-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cohen, Alexander T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maraveyas, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beyer-Westendorf, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Agnes Y.Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Folkerts, Kerstin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdelgawwad, Khaled</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Sanctis, Yoriko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fatoba, Samuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bamber, Luke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bach, Miriam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mantovani, Lorenzo G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:206</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:1-4</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2021.06.021</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">206</subfield><subfield code="j">2021</subfield><subfield code="h">1-4</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
| author |
Cohen, Alexander T. |
| spellingShingle |
Cohen, Alexander T. ddc 610 bkl 44.40 Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| authorStr |
Cohen, Alexander T. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.40 bkl Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a m am j b w jbw a y l ay ayl k f kf k a ka s y d sy syd s f sf l b lb m b mb l g m lg lgm |
| hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| hierarchy_parent_id |
ELV011105356 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011105356 |
| title |
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| ctrlnum |
(DE-627)ELV05544055X (ELSEVIER)S0049-3848(21)00381-9 |
| title_full |
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| author_sort |
Cohen, Alexander T. |
| journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
Cohen, Alexander T. |
| container_volume |
206 |
| physical |
4 |
| class |
610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Cohen, Alexander T. |
| doi_str_mv |
10.1016/j.thromres.2021.06.021 |
| dewey-full |
610 |
| title_sort |
patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – the cosimo study |
| title_auth |
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
| title_short |
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study |
| url |
https://doi.org/10.1016/j.thromres.2021.06.021 |
| remote_bool |
true |
| author2 |
Maraveyas, Anthony Beyer-Westendorf, Jan Lee, Agnes Y.Y. Folkerts, Kerstin Abdelgawwad, Khaled De Sanctis, Yoriko Fatoba, Samuel Bamber, Luke Bach, Miriam Mantovani, Lorenzo G. |
| author2Str |
Maraveyas, Anthony Beyer-Westendorf, Jan Lee, Agnes Y.Y. Folkerts, Kerstin Abdelgawwad, Khaled De Sanctis, Yoriko Fatoba, Samuel Bamber, Luke Bach, Miriam Mantovani, Lorenzo G. |
| ppnlink |
ELV011105356 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.thromres.2021.06.021 |
| up_date |
2024-07-06T17:33:31.024Z |
| _version_ |
1803851882586701824 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05544055X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624221626.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2021.06.021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001516.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05544055X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(21)00381-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cohen, Alexander T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maraveyas, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beyer-Westendorf, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Agnes Y.Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Folkerts, Kerstin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abdelgawwad, Khaled</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Sanctis, Yoriko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fatoba, Samuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bamber, Luke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bach, Miriam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mantovani, Lorenzo G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:206</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:1-4</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2021.06.021</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">206</subfield><subfield code="j">2021</subfield><subfield code="h">1-4</subfield><subfield code="g">4</subfield></datafield></record></collection>
|
| score |
7.4019957 |